{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:32:59Z","timestamp":1789162379767,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1023\/a:1019993018162","type":"journal-article","created":{"date-parts":[[2003,3,15]],"date-time":"2003-03-15T13:06:10Z","timestamp":1047733570000},"page":"227-230","source":"Crossref","is-referenced-by-count":17,"title":["Combination Chemotherapy with High-dose Methotrexate and Cytarabine with or without Brain Irradiation for Primary Central Nervous System Lymphomas"],"prefix":"10.1007","volume":"59","author":[{"given":"Antonello","family":"Calderoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Aebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5092028_CR1","unstructured":"O'Neill B, Janney C, Olson J, Cerhan J, Kurtin P, Schiff D, Kaplan R: The continuing increase in primary central nervous system non-Hodgkin's lymphoma (PCNSL): a surveillance, epidemiology and end results (SEER) analysis. Proc Annu Meet Am Soc Clin Oncol, 2001, p. 53a"},{"key":"5092028_CR2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1200\/JCO.1998.16.3.864","volume":"16","author":"JY Blay","year":"1998","unstructured":"Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P: High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16: 864\u2013871, 1998","journal-title":"J Clin Oncol"},{"key":"5092028_CR3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7326\/0003-4819-119-11-199312010-00007","volume":"119","author":"HA Fine","year":"1993","unstructured":"Fine HA, Mayer RJ: Primary central nervous system lymphoma. Ann Intern Med 119: 1093\u20131104, 1993","journal-title":"Ann Intern Med"},{"key":"5092028_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1008201717089","volume":"8","author":"M Reni","year":"1997","unstructured":"Reni M, Ferreri AJ, Garancini MP, Villa E: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 227\u2013234, 1997","journal-title":"Ann Oncol"},{"key":"5092028_CR5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, Akerley W, Mills P, Saris S, Hochberg F, Calabresi P, Egorin MJ: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16: 1561\u20131567, 1998","journal-title":"J Clin Oncol"},{"key":"5092028_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","volume":"10","author":"LM DeAngelis","year":"1992","unstructured":"DeAngelis LM, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635\u2013643, 1992","journal-title":"J Clin Oncol"},{"key":"5092028_CR7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","volume":"16","author":"LE Abrey","year":"1998","unstructured":"Abrey LE, DeAngelis LM, Yahalom J: Long-term survival in primary CNS lymphoma. J Clin Oncol 16: 859\u2013863, 1998","journal-title":"J Clin Oncol"},{"key":"5092028_CR8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1946::AID-CNCR19>3.0.CO;2-T","volume":"82","author":"AL Cheng","year":"1998","unstructured":"Cheng AL, Yeh KH, Uen WC, Hung RL, Liu MY, Wang CH: Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol. Cancer 82: 1946\u20131951, 1998","journal-title":"Cancer"},{"key":"5092028_CR9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9","volume":"89","author":"GM Mead","year":"2000","unstructured":"Mead GM, Bleehen NM, Gregor A, Bullimore J, Shirley D, Rampling RP, Trevor J, Glaser MG, Lantos P, Ironside JW, Moss TH, Brada M, Whaley JB, Stenning SP: A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 89: 1359\u20131370, 2000","journal-title":"Cancer"},{"key":"5092028_CR10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","volume":"19","author":"C Soussain","year":"2001","unstructured":"Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond AV: Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19: 742\u2013749, 2001","journal-title":"J Clin Oncol"},{"key":"5092028_CR11","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","volume":"18","author":"LE Abrey","year":"2000","unstructured":"Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18: 3144\u20133150, 2000","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019993018162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1019993018162\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1019993018162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:02:32Z","timestamp":1749632552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1019993018162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["5092028"],"URL":"https:\/\/doi.org\/10.1023\/a:1019993018162","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}